Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:55 AM
Ignite Modification Date:
2025-12-25 @ 3:55 AM
NCT ID:
NCT02605902
Eligibility Criteria:
Inclusion Criteria:
* Chronic tic disorder or Tourette syndrome according to DSM-5
* Age ≥18 years; Yale Global Tic Severity Scale (YGTSS) total tic score (TTS) \> 14 or \> 10 (for patients only with motor or vocal tics)
* Clinical Global Impression-Severity Score (CGI-S) \> 4
* Medication for tics and comorbidities must be on a stable dose for at least 6 weeks before entering the study
* Fluent German in speaking and writing
* Ability to give informed consent and signed informed consent
Exclusion Criteria:
* History of schizophrenia or pervasive developmental disorder
* Comorbid obsessive-compulsive disorder (OCD), attention deficit hyperactivity disorder (ADHD), depression, anxiety disorder when unstable and/or in need of an initial adjustment for a therapy
* History of behavioral treatment for tics
* Current illicit substance abuse or addiction (clinically diagnosed)
* Secondary tic disorder or other significant neurological and psychiatric disease
* No internet access or ability to use the internet
* Participation in a study with medicinal products or devices is not allowed within 6 weeks before inclusion or concurrent to this study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02605902
Study Brief:
Protocol Section:
NCT02605902